Phase III US trial of Allergy Therapeutics' grass pollen allergy vaccine, designated Pollinex Quattro Grass.

Trial Profile

Phase III US trial of Allergy Therapeutics' grass pollen allergy vaccine, designated Pollinex Quattro Grass.

Planning
Phase of Trial: Phase III

Latest Information Update: 22 Sep 2014

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary) ; Monophosphoryl lipid A
  • Indications Grass pollen hypersensitivity; Rhinoconjunctivitis; Seasonal allergic rhinitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Allergy Therapeutics
  • Most Recent Events

    • 07 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top